Conventional therapy and new antifungal drugs againstMalasseziainfections
- 24 October 2020
- journal article
- review article
- Published by Oxford University Press (OUP) in Medical Mycology
- Vol. 59 (3) , 215-234
Abstract
Malassezia yeasts are commensal microorganisms occurring on the skin of humans and animals causing dermatological disorders or systemic infections in severely immunocompromised hosts. Despite attempts to control such yeast infections with topical and systemic antifungals, recurrence of clinical signs of skin infections as well as treatment failure in preventing or treating Malassezia furfur fungemia have been reported most likely due to wrong management of these infections (e.g., due to early termination of treatment) or due to the occurrence of resistant phenomena. Standardized methods for in vitro antifungal susceptibility tests of these yeasts are still lacking, thus resulting in variable susceptibility profiles to azoles among Malassezia spp. and a lack of clinical breakpoints. The inherent limitations to the current pharmacological treatments for Malassezia infections both in humans and animals, stimulated the interest of the scientific community to discover new, effective antifungal drugs or substances to treat these infections. In this review, data about the in vivo and in vitro antifungal activity of the most commonly employed drugs (i.e., azoles, polyenes, allylamines, and echinocandins) against Malassezia yeasts, with a focus on human bloodstream infections, are summarized and their clinical implications are discussed. In addition, the usefulness of alternative compounds is discussed.Keywords
This publication has 143 references indexed in Scilit:
- Treatment of pityriasis versicolor with topical application of essential oil of Cymbopogon citratus (DC) Stapf - therapeutic pilot studyAnais Brasileiros de Dermatologia, 2013
- Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012Journal of Clinical Microbiology, 2012
- Peptides of the Constant Region of Antibodies Display Fungicidal ActivityPLOS ONE, 2012
- Effects of Thymol and Carvacrol, Constituents ofThymus vulgarisL. Essential Oil, on the Inflammatory ResponseEvidence-Based Complementary and Alternative Medicine, 2012
- Epidemiological Cutoffs and Cross-Resistance to Azole Drugs in Aspergillus fumigatusAntimicrobial Agents and Chemotherapy, 2008
- Toxicity and gastric tolerance of essential oils from Cymbopogon citratus, Ocimum gratissimum and Ocimum basilicum in Wistar ratsFood and Chemical Toxicology, 2008
- New advances in fatty acids as antimalarial, antimycobacterial and antifungal agentsProgress in Lipid Research, 2008
- Randomized comparative clinical trial of artemisia sieberi 5% lotion and clotrimazole 1% lotion for the treatment of pityriasis versicolorIndian Journal of Dermatology, 2008
- A Modified Christensen's Urea and CLSI Broth Microdilution Method for Testing Susceptibilities of SixMalasseziaSpecies to Voriconazole, Itraconazole, and KetoconazoleJournal of Clinical Microbiology, 2006
- Anti-inflammatory activity of tea (Camellia sinensis) root extractLife Sciences, 2003